Mirata Pharmaceuticals, LLC — Form D/A
Mirata Pharmaceuticals, LLC of PLYMOUTH MEETING, PA, a company, filed a Form D amendment with the SEC on 2019-01-14. The offering totals $8.0M, of which $7.1M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2019-01-14
- Form: D/A
- Accession: 0001192482-19-000024
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $8.0M
- Amount sold: $7.1M
- Remaining: $950K
- Investors: 11
- Date of first sale: 2018-06-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-313995
Issuer
- Name: Mirata Pharmaceuticals, LLC
- CIK: 0001742436
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 610 W. GERMANTOWN PIKE, SUITE 400, PLYMOUTH MEETING, PA, 19462
- Phone: 215-767-4184
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Matthew Callahan | Director | Plymouth Meeting, PA |
| Maurits Geerlings | Director | Devon, PA |
| Brian Hubbard | Director | San Diego, CA |
| John Johnson | Director | Chanhassen, MN |
| Joseph F Lovett | Director | Plymouth Meeting, PA |
| Jason Y Zhang | Director | Plymouth Meeting, PA |
| Matthew Callahan | Executive Officer | Plymouth Meeting, PA |
Other filings by this issuer (1)
More